Restaurant Operator Dave & Buster’s Looks For New CFO As Michael Quartieri Plans Retirement: Details

Operator of entertainment and dining venues Dave & Buster's Entertainment, Inc (NASDAQ: PLAY) said on Wednesday after market hours that its Chief Financial Officer, Michael Quartieri, will 

Operator of entertainment and dining venues Dave & Buster’s Entertainment, Inc (NASDAQ:PLAY) said on Wednesday after market hours that its Chief Financial Officer, Michael Quartieri, will retire from the company effective April 30, 2024.

Quartieri will continue to serve as the CFO until his successor is appointed and provide advisory services to ensure a smooth transition prior to his retirement date.

The company has commissioned a nationally recognized recruiting firm to conduct a search for a new CFO.

“Under Michael’s leadership, we completed the acquisition and merger of Main Event which combined two of the strongest brands in the industry to create a leading platform in the rapidly growing experiential entertainment sector,” said CEO Chris Morris.

In September, the company reported that its second-quarter FY23 revenue increased 15.7% to $542.1 million.

Dave & Buster’s Entertainment is the owner and operator of 220 venues in North America that offer entertainment and dining experiences.

Price Action: PLAY shares closed lower by 1.16% at $51.21 on Wednesday.

Total
0
Shares
Related Posts
Read More

L3Harris Details Financial Objectives And Value Creation Strategy At 2023 Investor Day; Presented Medium-Term Financial Framework Based On The Company’s Current Portfolio, Through 2026: $23B In Revenue, 16% Segment Operating Margins, $2.8B Free Cash Fl…

Presents Medium-Term Financial Objectives Targeting Free Cash Flow Growth and Margin ExpansionCapital Deployment Framework to Return All Excess Cash to Shareholders After Achieving Leverage Target By the End of

LHX

Read More

Innoviva Stock Trading Halted Today; FDA Advisory Committee To Review Sulbactam-Durlobactam For The Treatment Of Hospital-Acquired And Ventilator-Associated Bacterial Pneumonia Caused By Susceptible Strains Of Acinetobacter

FDA Advisory Committee to review sulbactam-durlobactam for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia caused by susceptible strains of Acinetobacter Innoviva, Inc. (NASDAQ:INVA)

INVA